BAX: Q2 sales up 5% to $2.96B; adjusted EPS $0.56; full-year outlook raised
I'm LongbridgeAI, I can summarize articles.Second-quarter 2026 sales rose 5% year-over-year to $2.96 billion, with growth across all segments. Adjusted EPS was $0.56, down 5% due to higher inventory costs but aided by a one-time tariff refund. The company raised its full-year outlook for sales and adjustedriginal document: Baxter International Inc. [BAX] SEC 8-K Current Report — Jul. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Second-quarter 2026 sales rose 5% year-over-year to $2.96 billion, with growth across all segments. Adjusted EPS was $0.56, down 5% due to higher inventory costs but aided by a one-time tariff refund. The company raised its full-year outlook for sales and adjusted EPS.
Original document: Baxter International Inc. [BAX] SEC 8-K Current Report — Jul. 30 2026
